Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126213701 | 12621370 | 1 | I | 20160802 | 20160804 | 20160804 | EXP | NO-DEXPHARM-20161681 | DEXCEL | BENT-ARE HANSEN, OYVIND BRUSERUD. HYPOMAGNESEMIA AS A POTENTIALLY LIFE-THREATENING ADVERSE EFFECT OF OMEPRAZOLE. OXFORD MEDICAL CASE REPORTS, 2016;7, 147?149 | 40.00 | YR | A | F | Y | 0.00000 | 20160804 | OT | NO | NO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126213701 | 12621370 | 1 | PS | OMEPRAZOLE. | OMEPRAZOLE | 1 | 20-40 MG/DAY | Y | Y | 0 | 20 | MG | |||||||
| 126213701 | 12621370 | 2 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | 20-40 MG/DAY | Y | Y | 0 | 40 | MG | |||||||
| 126213701 | 12621370 | 3 | C | ATORVASTATIN | ATORVASTATIN | 1 | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126213701 | 12621370 | 1 | Gastrooesophageal reflux disease |
| 126213701 | 12621370 | 2 | Gastrooesophageal reflux disease |
| 126213701 | 12621370 | 3 | Hypercholesterolaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126213701 | 12621370 | HO |
| 126213701 | 12621370 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126213701 | 12621370 | Hypomagnesaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |